TY - JOUR
T1 - Prevalence of COVID-19 in adolescents and youth compared with older adults in states experiencing surges
AU - Rumain, Barbara
AU - Schneiderman, Moshe
AU - Geliebter, Allan
N1 - Publisher Copyright:
© 2021 Public Library of Science. All rights reserved.
PY - 2021/3
Y1 - 2021/3
N2 - Purpose There has been considerable controversy regarding susceptibility of adolescents (10 19 years) and youth (15 24 years) to COVID-19. However, a number of studies have reported that adolescents are significantly less susceptible than older adults. Summer 2020 provided an opportunity to examine data on prevalence since after months of lockdowns, with the easing of restrictions, people were mingling, leading to surges in cases. Methods We examined data from Departments of Health websites in six U.S. states experiencing surges in cases to determine prevalence of COVID-19, and two prevalence-related measures, in adolescents and youth as compared to older adults. The two other measures related to prevalence were: (Percentage of cases observed in a given age group) ? (percentage of cases expected based on population demographics); and percentage deviation, or [(% observed % expected)/ %expected] x 100. Results Prevalence of COVID-19 for adolescents and for youth was significantly greater than for older adults (p .00001), as was percentage observed ? percentage expected (p .005). The percentage deviation was significantly greater in adolescents/youth than in older adults (p 0.00001) when there was an excess of observed cases over what was expected, and significantly less when observed cases were fewer than expected (p 0.00001). Conclusions Our results are contrary to previous findings that adolescents are less susceptible than older adults. Possible reasons for the findings are suggested, and we note that public health messaging targeting adolescents and youth might be helpful in curbing the pandemic. Also, the findings of the potential for high transmission among adolescents and youth, should be factored into decisions regarding school reopening.
AB - Purpose There has been considerable controversy regarding susceptibility of adolescents (10 19 years) and youth (15 24 years) to COVID-19. However, a number of studies have reported that adolescents are significantly less susceptible than older adults. Summer 2020 provided an opportunity to examine data on prevalence since after months of lockdowns, with the easing of restrictions, people were mingling, leading to surges in cases. Methods We examined data from Departments of Health websites in six U.S. states experiencing surges in cases to determine prevalence of COVID-19, and two prevalence-related measures, in adolescents and youth as compared to older adults. The two other measures related to prevalence were: (Percentage of cases observed in a given age group) ? (percentage of cases expected based on population demographics); and percentage deviation, or [(% observed % expected)/ %expected] x 100. Results Prevalence of COVID-19 for adolescents and for youth was significantly greater than for older adults (p .00001), as was percentage observed ? percentage expected (p .005). The percentage deviation was significantly greater in adolescents/youth than in older adults (p 0.00001) when there was an excess of observed cases over what was expected, and significantly less when observed cases were fewer than expected (p 0.00001). Conclusions Our results are contrary to previous findings that adolescents are less susceptible than older adults. Possible reasons for the findings are suggested, and we note that public health messaging targeting adolescents and youth might be helpful in curbing the pandemic. Also, the findings of the potential for high transmission among adolescents and youth, should be factored into decisions regarding school reopening.
UR - http://www.scopus.com/inward/record.url?scp=85102618770&partnerID=8YFLogxK
U2 - 10.1371/journal.pone.0242587
DO - 10.1371/journal.pone.0242587
M3 - Article
C2 - 33690600
AN - SCOPUS:85102618770
SN - 1932-6203
VL - 16
JO - PLoS ONE
JF - PLoS ONE
IS - 3 March
M1 - e0242587
ER -